The Effects of an Acute Dose of a Betalain-rich Concentrate on Repeated-sprint Cycling Performance and Recovery.
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Nutraceuticals
In brief
Betalains have well-known antioxidant and anti-inflammatory properties. Recent investigations examining the effects of a betalain-rich concentrate (BRC) on exercise and recovery performance show promise of BRC as an ergogenic aid. To date, no study has examined the effects of a single dose of a BRC on supramaximal performance and recovery. Therefore, the purpose of this study is to examine the effects of an acute dose of BRC on repeated-sprint cycling performance and recovery.
Key facts
- Study ID
- NCT06274385
- Run by
- Drexel University
- People needed
- 10
- Starts
- 2024-03-06
- Expected to finish
- 2025-08-01
- Last updated by the study team
- 2024-11-22
Who can join
Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy, recreationally active males and females
- Aged 18-40
- Free of disease or injury
You may not qualify if…
- Have any musculoskeletal injuries that could be made worse by participating in this study (e.g., sprain or strain of lower limb)
- Have documented medical conditions (i.e., hypertension, asthma, heart disease, diabetes) or exhibit signs and symptoms of medical conditions
- Taking any medication that would interfere with the interpretation of our results. These include, but are not limited to, anti-inflammatory drugs, antibiotics, anti-hypertensives, and any medicine controlling the digestive system.
Where it is running
- Drexel University - Health Sciences Building — Philadelphia, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.